Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Also Known As
founded date
Operating Status
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Fractyl Health
Fractyl Health uses Revita DMR to rejuvenate the lining of the duodenum.
Sector
Subsector
Location
total rounds
total raised
SageMedic
SageMedic develops a genome-free SAGE Direct Platform that increases clinical success rates for drugs in development.
Sector
Subsector
Location
total rounds
Biohope
Biohope develops diagnostic and therapeutic solutions for organ transplantation.
Sector
Subsector
Location
total rounds
total raised
Invizius
Invizius is a biotech company developing treatments to help hemodialysis patients live longer and feel better.
Sector
Subsector
Location
total rounds
total raised
Financials
Funding Rounds6
Number of Funding Rounds
Money Raised
Their latest funding was raised on 25.06.2024. Their latest investor Hatteras Venture Partners. Their latest round Series C
Co-Investors
Investors8
Number of lead investors
Number of investors
Hatteras Venture Partners
Hatteras Venture Partners invests in transformative companies in healthcare and related fields.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Longitude Capital
Longitude Capital is a venture capital firm that invests in biotechnology and medical technology companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Juliet Tammenoms Bakker
Ms. Bakker is a Managing Director and Founder of Longitude Capital. Prior to Longitude Capital, Ms. Bakker was a Managing Director of Pequot Ventures where she founded the life sciences investment practice. Prior to Pequot, she was Director, Strategic Planning and Director, Operations of Waste Management International. Previously, she was a sell-side equity analyst with Banque Paribas. Ms. Bakker began her career as an investment banker in the corporate finance department at PaineWebber. She currently serves on the boards of Alphaeon, Axonics Modulation Technologies, Encore Dermatology, Nalu, RxSight and Venus Concept. She has previously served on the boards of Ablation Frontiers (acquired by Medtronic), AqueSys (acquired by Allergan), CryoVascular Systems (acquired by Boston Scientific), Embolic Protection (acquired by Boston Scientific), Enteric Medical (acquired by Boston Scientific), eyeonics (acquired by Bausch+Lomb), Genyx Medical (acquired by C.R.Bard), Insulet (PODD), Precision Dermatology (acquired by Valeant Pharmaceuticals), and Sadra Medical (acquired by Boston Scientific). Ms. Bakker holds an M.P.A. from the John F. Kennedy School of Government at Harvard University and a B.Sc. from the College of Agriculture and Life Sciences at Cornell University (“CALS”), where she is a member of the CALS Advisory Council. Ms. Bakker is also a board member of the Boys and Girls Club of Greenwich.
current job
Intuitive Ventures
Intuitive Ventures supports early-stage start-ups to reach their major milestones.
Sector
Subsector
Keywords
Location
count Of Investments
People
Founders3
Paul Hindrichs
Paul Hindrichs is a veteran business leader and innovator with more than 20 years of medical device experience. He has served in various management capacities during his career, including positions with several other start-up and early stage medical device companies. Prior to founding Conventus, he worked for St. Jude Medical (SJM), Vascular Science, Inc., Optical Sensors, Inc., and Schneider USA (Pfizer). Most recently, he was responsible for the Structural Heart Business and Cardiac Technologies Group at SJM. Mr. Hindrichs earned a Bachelor of Science in Mechanical Engineering from the University of Minnesota and is a named inventor on 20 issued and 22 pending patent applications.
current job
organization founded
Paul Hindrichs
Michael Brenzel
Michael Brenzel is the Co-Founder of DyaMX.
current job
organization founded
Michael Brenzel
John Deedrick
John A. Deedrick is the Co-founder and Managing Director of Fourth Element Capital, a healthcare technology venture capital firm. He is Co-founder and Executive Chairman of ActivOrtho, Inc., DyaMX, Inc., CHIP II, Inc., as well as FourMation Medical Works, a new healthcare technology business creation and growth company. John is also President of CHIP Solutions, a business consulting firm that provides significant value-added services to individuals, private companies and public companies. From 2003-2012, John was a Co-founder and General Partner with Accuitive Medical Ventures (AMV). AMV has over $230 million in capital under management in its two medical device venture capital funds. AMV has a proprietary relationship with The Innovation Factory (TIF), a medical device incubator located in Duluth, GA. John was instrumental in fundraising, investment and management committee activities, building the portfolio and harvesting returns for AMV’s Limited Partners. John served as a Director for AMV’s investments in MyoScience, SoftScope, Nevro and Torax. He was significantly involved in deal flow, due diligence and risk identification/management for all AMV portfolio companies. Key exits from the portfolio include LipoSonix (Medicis), SoftScope Medical (Fujinon), Sadra Medical (Boston Scientific), Axogen (AXGN), Inogen (INGN), Wavetec (Alcon), Nevro (NVRO), AqueSys (Allergan), Torax Medical (JJ Ethicon) and most recently Neuronetics (STIM). Prior to joining AMV, John was a Venture Manager for Mayo Clinic Ventures (MCV). During his time at MCV, John managed investments in several emerging medical companies including Exact Sciences (EXAS), Circe Biomedical (Arbios), Ascension Orthopedics (Integra), Neotonus, CardiacAssist (LivaNova), Image-Guided Neurologics (Medtronic), TomoTherapy (AcuRay), Cerebral Vascular Applications (licensed), and Volcano Therapeutics (Philips). In addition, he was instrumental in the start-up of four Mayo-founded companies: Santarus (Salix), Copharos, TeraMedica (Fujifilm), and Torax Medical (J&J Ethicon).
current job
count Of Investments
John Deedrick
Employee Profiles3
Activity
Recent News2
The graph reveals the ratio (%) of positive news articles in a chosen time range